Gastroesophageal Reflux Disease
📧 Sign up to get email alerts when something new happens for Gastroesophageal Reflux Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-04-19FDA Approved: DEXLANSOPRAZOLE — Original Application (ENDO USA, Inc.)
FDA approved ENDO USA, Inc.'s original application for dexlansoprazole (DEXLANSOPRAZOLE) as a generic on ANDA 202294. The therapy is used fo…
-
CLINICAL_TRIALS withdrawal · 2017-04-14Clinical Trial Update: PPI Versus Placebo in Severe Functional Heartburn [NA]
A clinical trial evaluating a proton pump inhibitor versus placebo for severe functional heartburn was withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Correlation of Oropharyngeal Pepsin and Gastroesophageal (GE) Reflux
The study evaluated whether oropharyngeal pepsin levels correlate with gastroesophageal reflux in patients with GERD. The trial status is co…
-
CLINICAL_TRIALS withdrawal · 2017-04-10Clinical Trial Update: Correlation of High Resolution Esophageal Manometry With Symptoms
A clinical trial investigating the correlation between high-resolution esophageal manometry and patient symptoms has been withdrawn, involvi…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Feasibility of Placing Bravo PH Capsule in Proximal Esophagus [NA]
A clinical trial evaluated the feasibility of placing the Bravo pH capsule in the proximal esophagus for patients with gastroesophageal refl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Biology in Patients With Reflux Esophagitis
A completed clinical trial update from Vanderbilt University Medical Center investigating biology in patients with reflux esophagitis, a for…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use
A completed clinical trial from the University of Pennsylvania investigates how bone structure and bone mass change with long-term proton pu…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment? [Phase 4]
Phase 4 clinical trial evaluated whether laryngeal tissue changes in patients suspected of laryngopharyngeal reflux predict response to trea…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Response to Supplement and Placebo in GERD [NA]
A completed clinical trial conducted at Beth Israel Deaconess Medical Center compared a supplement to placebo for GERD symptoms, including h…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Gastroesophageal Reflux Treatment in Scleroderma [Phase 3]
Phase 3 trial evaluating treatment for gastroesophageal reflux disease in patients with scleroderma/systemic sclerosis has completed with re…
-
CLINICAL_TRIALS withdrawal · 2017-03-27Clinical Trial Update: Valvuloplasty as Alternative to Toupet Fundoplication for GERD [NA]
A clinical trial comparing valvuloplasty to Toupet fundoplication for gastroesophageal reflux disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Proton Pump Inhibitor (PPI) Responsive Eosinophilic Esophagitis EoE: Gastroesophageal Reflux Disease (GERD) or Eosinophilic Esophagitis (EoE)?
A Mayo Clinic-sponsored study on proton pump inhibitor-responsive eosinophilic esophagitis has completed, investigating whether PPI response…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Prospective Trial on the Clinical Feasibility of a New Full Thickness Endoscopic Plication Device for Patients With GERD. [NA]
A completed prospective clinical trial evaluated the feasibility of a new full-thickness endoscopic plication device for gastroesophageal re…
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Cough Reflex Sensitivity and Bronchial Hyper-responsiveness
A Mayo Clinic-sponsored clinical trial evaluating cough reflex sensitivity and bronchial hyper-responsiveness in patients with gastroesophag…
-
FDA approval · 2017-02-17FDA Approved: RABEPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for a generic rabeprazole sodium product from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Gastroesophageal Reflux and Cardiorespiratory Problems
A completed clinical trial from the University of Turin evaluated the link between gastroesophageal reflux and cardiorespiratory problems in…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study [NA]
This completed pilot trial evaluated the gastrointestinal microbiome in infants with gastroesophageal reflux disease who received proton pum…
-
FDA approval · 2017-02-07FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC (ANDA 077824).
-
FDA approval · 2017-02-03FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) by Haleon US Holdings LLC, adding a new form…
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Post-nasal Drainage as an Extraesophageal Manifestation of Reflux [Phase 2]
This document reports the completion of a Phase 2 clinical trial assessing postnasal drainage as an extraesophageal manifestation of gastroe…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication [NA]
A completed randomized trial evaluated the utility of placing esophageal stitches during laparoscopic fundoplication for gastroesophageal re…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. [Phase 2]
A Phase 2 trial assessed the effectiveness of Lavoltidine (AH234844) compared with Nexium (esomeprazole) and ranitidine for gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
A completed clinical trial update reporting on risk factors for Barrett's esophagus in patients with Barrett's esophagus, gastroesophageal r…
-
CLINICAL_TRIALS research · 2017-01-18Clinical Trial Update: Patient Education in Gastroesophageal Reflux Disease [NA]
A completed clinical trial evaluating patient education for gastroesophageal reflux disease, sponsored by the Norwegian University of Scienc…
-
FDA approval · 2017-01-09FDA Approved: NEXIUM 24HR CLEARMINIS — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application to add NEXIUM 24HR CLEARMINIS (esomeprazole magnesium) to Haleon US Holdings LLC's Nexium product li…